Cart
Free US shipping over $10
Proud to be B-Corp

Clinical Handbook of Psychotropic Drugs Adil S. Virani

Clinical Handbook of Psychotropic Drugs By Adil S. Virani

Clinical Handbook of Psychotropic Drugs by Adil S. Virani


$5.19
Condition - Good
Only 1 left

Summary

Features comparison charts with details of treatment options including dosing forms and strengths. This book offers advice regarding medication options and precautions. It also offers general information on medications and indications. It covers drug action, dosing, pharmacokinetics, and related areas.

Faster Shipping

Get this product faster from our US warehouse

Clinical Handbook of Psychotropic Drugs Summary

Clinical Handbook of Psychotropic Drugs by Adil S. Virani

"The Clinical Handbook of Psychotropic Drugs", now in its 18th edition, has become a standard reference for thousands of psychiatrists, psychologists, physicians, nurses, pharmacists, and indeed virtually all categories of mental health professionals. This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs. It features easy-to-read comparison charts with details of treatment options including available dosing forms and strengths. It offers clear advice regarding medication options and precautions. Potential interactions and side effects are summarized in comparison charts. Special precautions to consider when treating children and adolescents, pregnant patients, or the elderly are presented. It contains clearly written patient information sheets. Already widely regarded as the best practical guide on the market, the "Clinical Handbook of Psychotropic Drugs" now comes with an improved layout using color coding and readily recognizable icons for even more intuitive and user-friendly navigation. The book also offers general information on medications, availability, and indications; covers drug action, dosing, pharmacokinetics, and related areas; contains warnings and precautions; and offers patient-related information, such as considerations for special populations, nursing implications, and patient advice.

Clinical Handbook of Psychotropic Drugs Reviews

"Invaluable in clinical practice as well as in psychiatric research... an excellent teaching tool for medical students and residents... also widely used in the office by nurses and clinical coordinators." Corey Goldstein, MD, Rush University Medical Center "Packed with useful information and remarkably error-free... I recommend its purchase for use in office-based practices, as a reference on the wards, and as a ready reference and text for students" Nicholas Delva, MD, in Can J Psychiatry "I use it to teach psychiatry students - it is phenomenal!" Toby Goldsmith, MD, Vanderbilt University "An invaluable quick reference guide for the busy clinician." B.E. Leonard in Hum Psychopharmacol Clin Exp "Comprehensive... clearly and consistently organized... an ideal resource for rapid and straight-forward retrieval of essential clinical information... a 'must have' for those who work in mental health care." Marshall Cates, PharmD, in Ann Pharmacother "Should be available at all nursing stations." C. Lindsay DeVane, PharmD, in Am J Health Syst Pharm "A very practical handbook, packed with numerous charts and tables... up-to-date and most welcome straightforward guide to psychotropic drugs... a top quality publication full of essential information and data." Paul Shelley, in Int J Psychiatr Nurs Res"

Table of Contents

Antidepressants; Selective Serotonin Reuptake Inhibitors (SSRI); Norepinephrine Dopamine Reuptake Inhibitor; (NDRI); Selective Serotonin Norepinephrine Reuptake Inhibitor (SNRI); Serotonin-2 Antagonists/Reuptake Inhibitors (SARI); Noradrenergic/Specific Serotonergic Antidepressants (NaSSA); Non-Selective Cyclic Antidepressants; Monoamine Oxidase Inhibitors; Reversible Inhibitor of MAO-A (RIMA); Irreversible Monoamine Oxidase Inhibitors; Monoamine Oxidase B Inhibitor; Effects of Antidepressants on Neurotransmitters/Receptors; Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors; Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses; Frequency (per cent) of Adverse Reactions to MAOI Antidepressants at Therapeutic Doses; Antidepressant Doses and Pharmacokinetics; Switching Antidepressants; Antidepressant Augmentation Strategies; Electroconvulsive Therapy (ECT); Bright-Light Therapy (BLT); Repetitive Transcranial Magnetic Stimulation (rTMS); Antipsychotics (Neuroleptics); "Second-Generation" Antipsychotics/SGAs (Neuroleptics); "Third-Generation" Antipsychotic/TGA (Neuroleptics); "First Generation" Antipsychotics/FGAs; Effects of Antipsychotics on Neurotransmitters/Receptors; Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors; Frequency (per cent) of Adverse Reactions to Antipsychotics at Therapeutic Doses; Antipsychotic Doses and Pharmacokinetics; Comparison of Depot Antipsychotics; Extrapyramidal Side Effects of Antipsychotics; Switching Antipsychotics; Antipsychotic Augmentation Strategies; Agents for Treating Extrapyramidal Side Effects; Effects on Extrapyramidal Symptoms; Comparison of Agents for Treating Extrapyramidal Side Effects; Anxiolytic Agents; Benzodiazepines; Comparison of the Benzodiazepines; Buspirone; Hypnotics/Sedatives; Comparison of Hypnotics/Sedatives; Mood Stabilizers; Lithium; Anticonvulsants; Comparison of Anticonvulsants; Comparison of Adverse Reactions to Mood Stabilizers at Therapeutic Doses; L-Tryptophan; Drugs for ADHD; Psychostimulants; Atomoxetine; Comparison of Drugs for ADHD; Clonidine; Augmentation Strategies in ADHD; Drugs for Treatment of Dementia; Cholinesterase Inhibitors; Memantine; Comparison of Drugs for Treatment of Dementia; Sex-Drive Depressants; Comparison of Sex-Drive Depressants; Drugs of Abuse; Alcohol; Stimulants; Hallucinogens; Opiates/Narcotics; Inhalants/Aerosols; Gamma Hydroxy Butyrate (GHB)/Sodium Oxybate; Flunitrazepam (Rohypnol); Treatment of Substance Use Disorders; Disulfiram; Acamprosate; Naltrexone; Methadone; Buprenorphine; New Unapproved Treatments of Psychiatric Disorders; Adrenergic Agents; Calcium Channel Blockers; Dopaminergic Agents; GABA-Agents/Anticonvulsants; Serotonin Antagonists; Opioid Antagonists/Agonists; Steroid Biosynthesis Inhibitors; Immunomodulators; Hormones; Miscellaneous; Herbal and "Natural" Products; Glossary; Suggested Readings; Patient Information Sheets; Index of Drugs.

Additional information

CIN0889373698G
9780889373693
0889373698
Clinical Handbook of Psychotropic Drugs by Adil S. Virani
Used - Good
Hardback
Hogrefe Publishing
2009-05-08
374
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a used book - there is no escaping the fact it has been read by someone else and it will show signs of wear and previous use. Overall we expect it to be in good condition, but if you are not entirely satisfied please get in touch with us

Customer Reviews - Clinical Handbook of Psychotropic Drugs